Success Metrics

Completion Rate

0%(0/1)

Active Trials

2(67%)

Terminated

1(33%)

Phase Distribution

Ph phase_1

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

3(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Terminated(1)

Detailed Status

Active, not recruiting1

Recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

0.0%

Most Advanced

Phase 1

Trials by Phase

Phase 13 (100.0%)

Trials by Status

active_not_recruiting133%

recruiting133%

terminated133%

Recent Activity

2 active trials

Showing 3 of 3

active_not_recruitingphase_1

Study of Intra-articular Allocetra in Knee Osteoarthritis

NCT06233474

terminatedphase_1

Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis

NCT06522035

recruitingphase_1

Intra-articular Allocetra in Osteoarthritis of the of the Temporomandibular Joint (TMJ)

NCT06748651

Clinical Trials (3)

Showing 3 of 3 trials

NCT06233474Phase 1

Study of Intra-articular Allocetra in Knee Osteoarthritis

Active Not Recruiting

NCT06522035Phase 1

Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis

Terminated

NCT06748651Phase 1

Intra-articular Allocetra in Osteoarthritis of the of the Temporomandibular Joint (TMJ)

Recruiting

All 3 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 3